In vitro and in vivo analysis of the gram-negative bacteria-derived riboflavin precursor derivatives activating mouse MAIT cells

Journal of Immunology

Volumn 194, Issue 10, 2015, Pages 4641-4649

  Soudais, Claire ^a   Samassa, Fatoumata ^a   Sarkis, Manal ^a,b   Le Bourhis, Lionel ^a   Bessoles, Stéphanie ^a   Blanot, Didier ^c   Hervé, Mireille ^c   Schmidt, Frédéric ^b   Mengin Lecreulx, Dominique ^c   Lantz, Olivier ^a,b,d  

^a PSL RESEARCH UNIVERSITY   (France)

^b INSTITUT CURIE   (France)

^c INSTITUTE FOR INTEGRATIVE BIOLOGY OF THE CELL I2BC   (France)

^d Centre d'Investigation Clinique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO RIBITYL URACIL RIBOFLAVIN PRECURSOR; CD161 ANTIGEN; L SELECTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; RIBOFLAVIN DERIVATIVE; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG; HLA ANTIGEN CLASS 1; LIGAND; MR1 PROTEIN, MOUSE; RIBOFLAVIN;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; BACTERIAL STRAIN; CANDIDA ALBICANS; CD8+ T LYMPHOCYTE; CELL ACTIVATION; COCULTURE; CONTROLLED STUDY; FLOW CYTOMETRY; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUCOSAL ASSOCIATED INVARIANT T CELL; MYCOBACTERIUM SMEGMATIS; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SYNTHESIS; T LYMPHOCYTE; ANIMAL; C57BL MOUSE; DISEASE MODEL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MUCOSA; NATURAL KILLER T CELL; TRANSGENIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; IN VITRO TECHNIQUES; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUCOUS MEMBRANE; NATURAL KILLER T-CELLS; RIBOFLAVIN;

EID: 84929094958     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1403224     Document Type: Article

References (36)

1. Huang, S., E. Martin, S. Kim, L. Yu, C. Soudais, D. H. Fremont, O. Lantz, and T. H. Hansen. 2009. MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution. Proc. Natl. Acad. Sci. USA 106: 8290-8295.
2. Riegert, P., V. Wanner, and S. Bahram. 1998. Genomics, isoforms, expression, and phylogeny of the MHC class I-related MR1 gene. J. Immunol. 161: 4066-4077.
3. Treiner, E., L. Duban, S. Bahram, M. Radosavljevic, V. Wanner, F. Tilloy, P. Affaticati, S. Gilfillan, and O. Lantz. 2003. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 422: 164-169.
4. Croxford, J. L., S. Miyake, Y. Y. Huang, M. Shimamura, and T. Yamamura. 2006. Invariant V(alpha)19i T cells regulate autoimmune inflammation. Nat. Immunol. 7: 987-994.
5. Kawachi, I., J. Maldonado, C. Strader, and S. Gilfillan. 2006. MR1-restricted V alpha 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response. J. Immunol. 176: 1618-1627.
6. Martin, E., E. Treiner, L. Duban, L. Guerri, H. Laude, C. Toly, V. Premel, A. Devys, I. C. Moura, F. Tilloy, et al. 2009. Stepwise development of MAIT cells in mouse and human. PLoS Biol. 7: e54. Available at: http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1000054.
7. Gold, M. C., S. Cerri, S. Smyk-Pearson, M. E. Cansler, T. M. Vogt, J. Delepine, E. Winata, G. M. Swarbrick, W. J. Chua, Y. Y. Yu, et al. 2010. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol. 8: e1000407. Available at: http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1000407.
8. Le Bourhis, L., E. Martin, I. Péguillet, A. Guihot, N. Froux, M. Coré, E. Lévy, M. Dusseaux, V. Meyssonnier, V. Premel, et al. 2010. Antimicrobial activity of mucosal-associated invariant T cells. Nat. Immunol. 11: 701-708.
9. Kjer-Nielsen, L., O. Patel, A. J. Corbett, J. Le Nours, B. Meehan, L. Liu, M. Bhati, Z. Chen, L. Kostenko, R. Reantragoon, et al. 2012. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491: 717-723.
10. Corbett, A. J., S. B. Eckle, R. W. Birkinshaw, L. Liu, O. Patel, J. Mahony, Z. Chen, R. Reantragoon, B. Meehan, H. Cao, et al. 2014. T-cell activation by transitory neo-antigens derived from distinct microbial pathways. Nature 509: 361-365.
11. Gold, M. C., J. E. McLaren, J. A. Reistetter, S. Smyk-Pearson, K. Ladell, G. M. Swarbrick, Y. Y. Yu, T. H. Hansen, O. Lund, M. Nielsen, et al. 2014. MR1-restricted MAIT cells display ligand discrimination and pathogen selectivity through distinct T cell receptor usage. J. Exp. Med. 211: 1601-1610.
12. Reantragoon, R., L. Kjer-Nielsen, O. Patel, Z. Chen, P. T. Illing, M. Bhati, L. Kostenko, M. Bharadwaj, B. Meehan, T. H. Hansen, et al. 2012. Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor. J. Exp. Med. 209: 761-774.
13. Goldfinch, N., P. Reinink, T. Connelley, A. Koets, I. Morrison, and I. Van Rhijn. 2010. Conservation of mucosal associated invariant T (MAIT) cells and the MR1 restriction element in ruminants, and abundance of MAIT cells in spleen. Vet. Res. 41: 62.
14. Tilloy, F., E. Treiner, S. H. Park, C. Garcia, F. Lemonnier, H. de la Salle, A. Bendelac, M. Bonneville, and O. Lantz. 1999. An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals. J. Exp. Med. 189: 1907-1921.
15. Young, M. H., L. U'Ren, S. Huang, T. Mallevaey, J. Scott-Browne, F. Crawford, O. Lantz, T. H. Hansen, J. Kappler, P. Marrack, and L. Gapin. 2013. MAIT cell recognition of MR1 on bacterially infected and uninfected cells. PLoS ONE 8: e53789. Available at: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0053789.
16. López-Sagaseta, J., C. L. Dulberger, A. McFedries, M. Cushman, A. Saghatelian, and E. J. Adams. 2013. MAIT recognition of a stimulatory bacterial antigen bound to MR1. J. Immunol. 191: 5268-5277.
17. Patel, O., L. Kjer-Nielsen, J. Le Nours, S. B. Eckle, R. Birkinshaw, T. Beddoe, A. J. Corbett, L. Liu, J. J. Miles, B. Meehan, et al. 2013. Recognition of vitamin B metabolites by mucosal-associated invariant T cells. Nat. Commun. 4: 2142.
18. Georgel, P., M. Radosavljevic, C. Macquin, and S. Bahram. 2011. The nonconventional MHC class I MR1 molecule controls infection by Klebsiella pneumoniae in mice. Mol. Immunol. 48: 769-775.
19. Meierovics, A., W. J. Yankelevich, and S. C. Cowley. 2013. MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection. Proc. Natl. Acad. Sci. USA 110: E3119-E3128. Available at: http://www.pnas.org/content/110/33/E3119.long.
20. Amann, E., B. Ochs, and K. J. Abel. 1988. Tightly regulated tac promoter vectors useful for the expression of unfused and fused proteins in Escherichia coli. Gene 69: 301-315.
21. Vieira, J., and J. Messing. 1982. The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene 19: 259-268.
22. Pompeo, F., J. van Heijenoort, and D. Mengin-Lecreulx. 1998. Probing the role of cysteine residues in glucosamine-1-phosphate acetyltransferase activity of the bifunctional GlmU protein from Escherichia coli: site-directed mutagenesis and characterization of the mutant enzymes. J. Bacteriol. 180: 4799-4803.
23. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 97: 6640-6645.
24. Miller, J. H. 1972. Experiments in Molecular Genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
25. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
26. Dagert, M., and S. D. Ehrlich. 1979. Prolonged incubation in calcium chloride improves the competence of Escherichia coli cells. Gene 6: 23-28.
27. Maunder, P., P. M. Finglas, A. I. Mallet, F. A. Mellon, M. Aaqib Razzaque, B. Ridge, L. Vahteristo, and C. Witthoft. 1999. The synthesis of folic acid, multiply labelled with stable isotopes, for bio-availability studies in human nutrition. J. Chem. Soc., Perkin Trans. 11311-1324.
28. Taylor, E. C., R. N. Henrie, and R. C. Portnoy. 1978. Pteridines. 44. A convenient synthesis of 6-formylpterin. J. Org. Chem. 43: 736-737.
29. Taylor, E. C., and T. Kobayashi. 1973. Pteridines. XXXII. 2-Amino-3-cyano-5-chloromethylpyrazine 1-oxide and its conversion to 6-alkenyl-substituted pteridines. J. Org. Chem. 38: 2817-2821.
30. Wang, Y., and C. T. Ho. 2012. Flavour chemistry of methylglyoxal and glyoxal. Chem. Soc. Rev. 41: 4140-4149.
31. Riddle, V., and F. W. Lorenz. 1968. Nonenzymic, polyvalent anion-catalyzed formation of methylglyoxal as an explanation of its presence in physiological systems. J. Biol. Chem. 243: 2718-2724.
32. Huang, S., S. Gilfillan, S. Kim, B. Thompson, X. Wang, A. J. Sant, D. H. Fremont, O. Lantz, and T. H. Hansen. 2008. MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells. J. Exp. Med. 205: 1201-1211.
33. Reantragoon, R., A. J. Corbett, I. G. Sakala, N. A. Gherardin, J. B. Furness, Z. Chen, S. B. Eckle, A. P. Uldrich, R. W. Birkinshaw, O. Patel, et al. 2013. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosalassociated invariant T cells. J. Exp. Med. 210: 2305-2320.
34. Eckle, S. B., R. W. Birkinshaw, L. Kostenko, A. J. Corbett, H. E. McWilliam, R. Reantragoon, Z. Chen, N. A. Gherardin, T. Beddoe, L. Liu, et al. 2014. A molecular basis underpinning the T cell receptor heterogeneity of mucosalassociated invariant T cells. J. Exp. Med. 211: 1585-1600.
35. López-Sagaseta, J., C. L. Dulberger, J. E. Crooks, C. D. Parks, A. M. Luoma, A. McFedries, I. Van Rhijn, A. Saghatelian, and E. J. Adams. 2013. The molecular basis for Mucosal-Associated Invariant T cell recognition of MR1 proteins. Proc. Natl. Acad. Sci. USA 110: E1771-E1778. Available at: http://www.pnas.org/content/110/19/E1771.long.
36. Marx, H., D. Mattanovich, and M. Sauer. 2008. Overexpression of the riboflavin biosynthetic pathway in Pichia pastoris. Microb. Cell Fact. 7: 23.